Ozama Ismail

3.1k total citations · 2 hit papers
26 papers, 1.5k citations indexed

About

Ozama Ismail is a scholar working on Radiology, Nuclear Medicine and Imaging, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Ozama Ismail has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Cellular and Molecular Neuroscience and 9 papers in Physiology. Recurrent topics in Ozama Ismail's work include Advanced Neuroimaging Techniques and Applications (12 papers), Alzheimer's disease research and treatments (9 papers) and Cerebrospinal fluid and hydrocephalus (7 papers). Ozama Ismail is often cited by papers focused on Advanced Neuroimaging Techniques and Applications (12 papers), Alzheimer's disease research and treatments (9 papers) and Cerebrospinal fluid and hydrocephalus (7 papers). Ozama Ismail collaborates with scholars based in United Kingdom, United States and Ireland. Ozama Ismail's co-authors include Mark F. Lythgoe, Jack A. Wells, Ian F. Harrison, Payam Nahavandi, Yolanda Ohene, Tracey K. Murray, Michael J. O’Neill, Niall Colgan, Erlend A. Nagelhus and Ole Petter Ottersen and has published in prestigious journals such as Nature Communications, PLoS ONE and NeuroImage.

In The Last Decade

Ozama Ismail

26 papers receiving 1.5k citations

Hit Papers

Impaired glymphatic function and clearance of tau in an A... 2020 2026 2022 2024 2020 2022 100 200 300 400

Peers

Ozama Ismail
Simon Sanggaard United States
Ozama Ismail
Citations per year, relative to Ozama Ismail Ozama Ismail (= 1×) peers Simon Sanggaard

Countries citing papers authored by Ozama Ismail

Since Specialization
Citations

This map shows the geographic impact of Ozama Ismail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ozama Ismail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ozama Ismail more than expected).

Fields of papers citing papers by Ozama Ismail

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ozama Ismail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ozama Ismail. The network helps show where Ozama Ismail may publish in the future.

Co-authorship network of co-authors of Ozama Ismail

This figure shows the co-authorship network connecting the top 25 collaborators of Ozama Ismail. A scholar is included among the top collaborators of Ozama Ismail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ozama Ismail. Ozama Ismail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simon, Matthew, Marie Xun Wang, Ozama Ismail, et al.. (2022). Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid β plaque formation in mice. Alzheimer s Research & Therapy. 14(1). 59–59. 144 indexed citations breakdown →
2.
Ismail, Ozama, Martin M. Pike, Wenri Zhang, & Anusha Mishra. (2022). Cerebrovascular Dysfunction at the Intersection of Ischemia and Alzheimer’s Disease. Alzheimer s & Dementia. 18(S3). 1 indexed citations
3.
Harrison, Ian F., Ozama Ismail, Asif Machhada, et al.. (2020). Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model. Brain. 143(8). 2576–2593. 403 indexed citations breakdown →
4.
Sokolska, Magdalena, Adriana Terezinha Neves Novellino Alves, Ian F. Harrison, et al.. (2020). Non-Invasive MRI of Blood–Cerebrospinal Fluid Barrier Function. Nature Communications. 11(1). 2081–2081. 71 indexed citations
6.
Harrison, Ian F., Bernard Siow, Ozama Ismail, et al.. (2018). Non-invasive imaging of CSF-mediated brain clearance pathways via assessment of perivascular fluid movement with diffusion tensor MRI. eLife. 7. 128 indexed citations
7.
Ohene, Yolanda, Ian F. Harrison, Payam Nahavandi, et al.. (2018). Non-invasive MRI of brain clearance pathways using multiple echo time arterial spin labelling: an aquaporin-4 study. NeuroImage. 188. 515–523. 115 indexed citations
8.
O'Callaghan, J.M., Holly E. Holmes, Nick Powell, et al.. (2017). Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease. NeuroImage. 159. 334–345. 43 indexed citations
9.
Holmes, Holly E., Nick Powell, Da Ma, et al.. (2017). Comparison of In Vivo and Ex Vivo MRI for the Detection of Structural Abnormalities in a Mouse Model of Tauopathy. Frontiers in Neuroinformatics. 11. 20–20. 39 indexed citations
10.
Colgan, Niall, Balaji Ganeshan, Ian F. Harrison, et al.. (2017). In Vivo Imaging of Tau Pathology Using Magnetic Resonance Imaging Textural Analysis. Frontiers in Neuroscience. 11. 599–599. 8 indexed citations
11.
Ismail, Ozama, Ian F. Harrison, Jack A. Wells, et al.. (2017). [IC‐P‐024]: INVESTIGATING GLYMPHATIC FUNCTION DURING EARLY TAU PATHOLOGY USING DYNAMIC CONTRAST‐ENHANCED MRI. Alzheimer s & Dementia. 13(7S_Part_1). 1 indexed citations
12.
Colgan, Niall, Bernard Siow, John M. O’Callaghan, et al.. (2015). Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease. NeuroImage. 125. 739–744. 154 indexed citations
13.
Ismail, Ozama, Ian F. Harrison, Holly E. Holmes, et al.. (2015). P1‐029: Imaging the efficacy of microtubule stabilizing agent epothilone d in the rtg4510 mouse model of tauopathy. Alzheimer s & Dementia. 11(7S_Part_7). 2 indexed citations
14.
Chen, Jing, Neil J. Ingham, Simon Clare, et al.. (2013). Mcph1-Deficient Mice Reveal a Role for MCPH1 in Otitis Media. PLoS ONE. 8(3). e58156–e58156. 46 indexed citations
15.
Migdalska‐Richards, Anna, Louise van der Weyden, Ozama Ismail, et al.. (2012). Modeling Partial Monosomy for Human Chromosome 21q11.2-q21.1 Reveals Haploinsufficient Genes Influencing Behavior and Fat Deposition. PLoS ONE. 7(1). e29681–e29681. 9 indexed citations
16.
Bosman, Erika A., Jeanne Estabel, Ozama Ismail, et al.. (2012). Omi, a recessive mutation on chromosome 10, is a novel allele of Ostm1. Mammalian Genome. 24(1-2). 44–53. 3 indexed citations
17.
Gerdin, Anna-Karin, Natalia Igosheva, Ozama Ismail, et al.. (2012). Experimental and husbandry procedures as potential modifiers of the results of phenotyping tests. Physiology & Behavior. 106(5). 602–611. 33 indexed citations
18.
Migdalska‐Richards, Anna, Louise van der Weyden, Ozama Ismail, et al.. (2012). Generation of the Sotos syndrome deletion in mice. Mammalian Genome. 23(11-12). 749–757. 13 indexed citations
19.
Al‐Mahdawi, Sahar, Ricardo Mouro Pinto, Ozama Ismail, et al.. (2007). The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues. Human Molecular Genetics. 17(5). 735–746. 200 indexed citations
20.
Ismail, Ozama, Dhaval Varshney, Stefania Lymperi, et al.. (1996). Human molecular genetics. The International Journal of Biochemistry & Cell Biology. 28(12). 1418–1418. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026